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ABSTRACT
Title: Decreasing Post-Operative Nausea and Vomiting Through Stimulation of the Pericardium6 Acupoint
Background: Post-operative nausea and vomiting (PONV) is one of the most common side
effects following anesthesia. Effects of PONV can cause significant patient distress, morbidity,
and increase healthcare costs. Despite the use of newer pharmacological drugs, PONV still
occurs in up to 25% of patients, warranting the use of additional means to control PONV that are
simple, cost-effective, and non-invasive (Trueman, 2011).
Purpose: The purpose of this case report/independent study is to determine if the addition of P-6
acupoint stimulation reduces the incidence of post-operative nausea and vomiting in surgical
patients.
Process: A comprehensive review of literature was completed using the PubMed, CINAHL, and
Cochrane database from the Harley E. French Library of the Health Sciences website. The
findings were reviewed and evaluated to determine relevancy to the research topic.
Results: P6 acupressure is effective as an alternative or adjuvant therapy for prevention of
PONV in low to moderate risk patients. When used in conjunction, P6 acustimulation and
modern antiemetic treatment may provide a synergistic effect that can greatly decrease the
incidence of PONV.
Implications: P6 acupoint stimulation is a non-invasive and non-pharmacological technique
examined to decreased PONV.
Keywords: P6 acupoint, Neiguan P-6, pericardium, acupressure, nausea and vomiting,
transcutaneous electric nerve stimulator, and electro-acupuncture.
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Management of Post-Operative Nausea and Vomiting Through Stimulation of the
Pericardium-6 Acupoint
Post-operative nausea and vomiting (PONV) is one of the most frequent complaints
following surgery. In addition to impairing the patient’s comfort, it can lead to various
complications, some of which are severe and life threating (Trueman, 2011). Various
pharmaceutical agents are currently being used as the standard to treat PONV, but with limited
success. The side effects and cost profiles of the current treatment modalities reinforce the belief
that there is opportunity for improvement in managing PONV. The primary research question
investigated in this independent study is: Does the addition of Pericardium-6 acupoint
stimulation decrease the incidence of post-operative nausea and vomiting when used alone, or in
combination with other traditional pharmacologic antiemetics?
Case Report
A 25-year old, 72 kg, 165 cm Caucasian female presented for a robotic assisted
laparoscopic cholecystectomy. The patient denied any allergies. Her medical history included
back pain, myofascial pain, sinusitis, anxiety, and occasional heartburn. The patient denied
alcohol use, cigarettes, or street drugs. Her surgical history included prior cesarean section and
laparoscopic hernia repair. Current medications included acetaminophen, hydrocodoneacetaminophen 10-325 (Norco), tizanidine, and cetirizine. The patient reported a history of postoperative nausea and vomiting with her two prior anesthetics that each lasted approximately 12
hours post procedure.
The patient was given an American Society of Anesthesiologists physical status level of
2. The patient received an assessed Mallampati score of 2, thyromental distance of 3
fingerbreadths, and displayed full neck range of motion. Preoperative vital signs were as follows:

P6 ACUPRESSURE IN DECREASING PONV

5

blood pressure 116/71, heart rate 82, respiratory rate 14, pulse oximetry 98%, and temperature
98.6 degrees Fahrenheit. When the patient arrived to the preoperative holding area, a
transdermal scopolamine patch was placed behind the patient’s ear. Thirty minutes later the
patient received midazolam 2 milligrams (mg) and ondansetron 4 mg intravenously (IV). The
patient was transported to the operating room where she was assisted onto the operating room
table. Standard monitors were applied and included a non-invasive blood pressure cuff on her
left upper extremity, finger pulse oximeter, 5-lead electrocardiogram (EKG), and a bispectral
index (BIS) monitor. Initial vital signs prior to induction were: blood pressure 112/70, heart rate
78, respiratory rate 12, and pulse oximetry 98%. The patient was pre-oxygenated via facemask at
10 liter per minute (LPM) for five minutes. After pre-oxygenation, the following medications
were administered IV: lidocaine 50 mg, fentanyl 150 mcg, propofol 160 mg, and rocuronium 30
mg. A 7.0 mm, cuffed, endotracheal tube (ETT) was placed via direct laryngoscopy utilizing a
Macintosh 3 blade and a grade 1 view was noted. Correct placement of the ETT was confirmed
with the auscultation of bilateral breath sounds and the presence of an ETCO2 waveform.
The endotracheal tube was secured with tape and the patient was placed on the ventilator
in a volume control mode with a respiratory rate of 12, tidal volume 550 milliliters (mL), and
positive end expiratory pressure (PEEP) of 4. Fresh gas flows were decreased to oxygen 1 LPM
and air 1 LPM. A total intravenous anesthesia technique was performed utilizing a propofol
infusion starting at 175 mcg/kg/min. Decadron 5 mg IV was administered for additional nausea
prophylaxis and cefazolin 1 gram IV was administered prior to incision for a preoperative
antibiotic.
Due to the ease of application and administration, P6 acustimulation was applied
following induction using a traditional nerve stimulator in accordance with preoperative
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education. Two surface electrodes were placed on the P6 acupressure point on the patient’s right
arm. The proximal positive electrode was placed between the tendons of the palmaris longus and
the flexor carpi radialis 1 cm proximal to the P6 acupressure point. The distal negative electrode
was placed 2 cm distal to the P6 acupoint. Each electrode was connected to the nerve stimulator
and tetanic stimulation at 50 Hz for 5 seconds was delivered every 10 minutes following
induction, for the duration of the procedure. The patient was repositioned with her arms abducted
less than 90 degrees and placed in a slight Trendelenburg position. Incision was made and
abdominal insufflation was initiated and maintained between 15 – 20 mmHg.
The ventilation mode was changed to a pressure control ventilation setting due to
increased peak airway pressures (PAP) with a rate of 12, inspiratory pressure of 25 cm H20, and
PEEP of 4. PAP reduced with delivery of adequate tidal volumes and end tidal carbon dioxide
(EtCO2) levels maintained between 30 – 35 mmHg. One dose of ephedrine 5mg was
administered IV for a non-invasive blood pressure reading of 90/49, with a mean atrial pressure
(MAP) of 62, with a subsequent blood pressure reading of 105/67 (MAP 79). One additional
dose of fentanyl 50 mcg was administered during the case for an increased heart rate of 88. The
patient was also administered an additional dose of rocuronium 10 mg due to surgeon request for
increased paralysis. The patient’s vital signs remained stable throughout the case with a MAP >
65, heart rate 68-88, pulse oximetry > 97 %, and BIS of 39-50.
Near conclusion of the surgical procedure, glycopyrrolate 0.4 mg and neostigmine 2 mg
were administered IV for reversal of neuromuscular paralysis. Subsequent twitches revealed 4
equally strong twitches, with 5 seconds of sustained tetany without fade. Ondansetron 4 mg IV
was also re-dosed prior to emergence for additional nausea prophylaxis. A soft gauze bite block
was placed in the patient’s mouth. Spontaneous respirations were noted and the propofol infusion
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was discontinued. Ketorolac 30 mg was given for additional pain control post operatively. The
total surgical time was 117 minutes. Extubation criteria was achieved as evidence by stable
hemodynamics, a regular respiratory rate of 10 breaths per minute, consistent tidal volumes of >
350 mL, appropriate response to command, and adequate head lift strength. The patient’s airway
was suctioned and extubated without complication. Oxygen via nasal cannula was applied at 4
LPM, and the patient was assisted in transfer to a transport bed.
Upon arrival to the Post Anesthesia Care Unit (PACU), the patient was awake, alert, and
responding appropriately. She denied any pain or nausea. The post anesthesia evaluation was
completed on post-operative day 1. The patient complained of only minor nausea when initially
eating for the first time the evening of surgery. The patient denied any further episodes of
nausea, vomiting, or dry heaving/retching throughout her hospital stay. She was discharged
home post-operative day 1 without any further incidence.
Review of Literature
Risk Factors
A diverse range of chemical, mechanical, and psychological emetic stimuli influences the
perioperative etiology of PONV. Primary risk factors associated with PONV can be patient
specific, related to the anesthetic chosen, or surgery related (Nagelhout & Plaus, 2012; Trueman,
2011; Cheong, Zhang, Huang, & Zhang, 2013). Patient related risk factors include: female
gender, age less than 50 years old, non-smoker, history of PONV, anxiety, and a history of
motion sickness. The use of volatile anesthetics, nitrous oxide, and opioids are all anesthetic
related risk factors. The specific type of surgery, such as laparoscopic, strabismus, craniotomy,
breast, plastic, gynecologic, orthopedic, and any surgery lasting over one hour also increases the
risk of PONV. Lastly, the experience of the surgeon is often overlooked as a risk factor.
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Inexperienced surgeons increase the incidence of PONV due to longer surgical times and
unnecessary handling of tissues (Nunley, Wakim, & Guinne, 2008).
Due to the cost and potential side effects of commonly used pharmacological agents,
identification of high-risk PONV patients should be an important part of the preoperative
evaluation. Trueman (2011) states, “female gender, non-smoking status, and a history of PONV
or motion sickness remain the strongest predictors of PONV” (p. 39). Knowing and identifying
the patient-specific risk factors can help manage nausea and vomiting from a prophylactic
approach, rather than a therapeutic approach.
Etiology of Post Operative Nausea and Vomiting
Nausea and vomiting are caused by stimulation of neurologic mechanisms found in the
gastrointestinal tract and brain, with the central nervous system (CNS) serving as the control
central for regulation (Nunley et al., 2008; Trueman, 2011). The CNS integrates information
received from the peripheral sensors and cerebral cortex, activating the autonomic nervous
system (ANS). These efferent pathways travel within cranial nerves V, VII, IX, X, and XII to the
upper and lower gastrointestinal tract, diaphragm, and abdominal muscles to produce vomiting
(Becker, 2010).
The two principal anatomic sites involved in CNS control of nausea and vomiting are the
vomiting center and the chemoreceptor trigger zone (CTZ). The vomiting center is located in the
medulla oblongata where stimulation occurs via histamine, dopamine, serotonin, and
acetylcholine (Nunley et al., 2008). The afferent fibers of the sympathetic and parasympathetic
nervous system transmit impulses to the vomiting center in the medulla. The CTZ is located in
the postrema of the fourth cerebral ventricle, adjacent to the vomiting center (Becker, 2010;
Nunley et al., 2008). The CTZ lacks protection from the blood brain barrier, making it
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susceptible to stimuli via neurotransmitters, emetogenic toxins, metabolites, and drugs
circulating in the blood or cerebrospinal fluid (Nunley et al., 2008). The CTZ is stimulated by
dopamine, serotonin, opioids, and certain anesthetic agents (Trueman, 2011). The CTZ and
vomiting center are connected by the fasciculus solitarious, and is the site where many
antiemetic agents work by blocking muscarinic, cholinergic, enkalphin, and histamine receptors
(Becker, 2010).
Acupressure
The use of alternative means to decrease PONV is a topic of ongoing investigation.
Historically the Pericardium-6 (P6) acupoint is widely considered to be the “pre-eminent point to
treat nausea and vomiting of any etiology” (Trueman, 2011, p. 37). The Pericardium-6 (P6), also
referred to as the Neiguan-6, acupoint is located between the tendons of the palmaris longus and
flexor carpi radialis muscles, 4 cm proximal to the wrist crease. Recent clinical trials have shown
promise that P6 acustimulation displays anti-emetic qualities, with the benefit of a favorable
side-effect profile. If shown to be an efficacious therapy in the management of post-operative
nausea and vomiting, either as a replacement method or in conjunction with traditional
antiemetics, it may provide the anesthetist with a cost-effective and safe mechanism to reduce
PONV and overall distress of the patient.
Acupressure is delivered via means of physical, mechanical, or electrical pressure
applied over specific meridians of the body. Although the precise mechanisms that make
acustimulation effective are not completely understood, a series of physiological events are
thought to occur following stimulation of an acupoint. Initially afferent type I and II nerve fibers
are stimulated, sending impulses to the spinal cord and periaqueductal gray matter in the
midbrain (Nunley et al., 2008). Subsequently enkephalins and endorphins are released via
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endorphogenic cells, with levels shown to be significantly higher in patients’ cerebrospinal fluid
following acupressure (Trueman, 2011). Endorphins in turn, block signals from the CTZ.
Stimulation of the hypothalamopituitary axis produces a release of beta-endorphin and
adrenocorticotropic hormone (ACTH) from the pituitary gland (Ertas et al., 2015). Enkephalin,
beta-endorphin, and ACTH exert their antiemetic action by modifying serotonin release. The
combination of the above responses act to block nausea and vomiting stimuli and calm the
gastrointestinal tract, thus countering PONV.
Various methods are available to deliver stimulation to the P6 acupuncture site.
Noninvasive techniques include acupressure through direct finger pressure, or simple band
devices that provide continuous pressure via direct contact with the site. Commercially available
electro-stimulation devices such as a TENS unit or ReliefBand also provide noninvasive
stimulation through small electrical currents through the skin. More recently, interest has gained
in providing noninvasive electro-stimulation with the use of a traditional nerve stimulator while
monitoring neuromuscular blockade. Invasive stimulation techniques include needle
acupuncture, electro-acupuncture, and dextrose injections. Invasive techniques are typically more
time consuming and carry a higher incidence of side effects due to piercing of the skin.
Trueman (2011) found that “few trials have compared stimulation protocols to deliver P6
acustimulation, probably due to the large population that would be required” (p. 41). Other
studies have found that non-invasive techniques were equally as effective as invasive techniques
(Dundee, 1990; Dundee et al., 1989). Lee and Fan (2011) performed a Cochrane Review that
included 40 randomized control trials involving 4858 surgical participants undergoing various
techniques of P6 acustimulation. They concluded that the invasive and noninvasive techniques
for P6 acustimulation produced similar effects. Noninvasive acustimulation via transcutaneous or
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electrical methods likely provides the fastest, safest, and most readily usable treatment modality
for the anesthesia provider. For this reason the focus of the literature review will remain on the
application and efficaciousness of acupressure at the P6 site in general, and not as a specific
modality of providing P6 stimulation, as it relates to the prevention of PONV.
P6 Acustimulation vs. Placebo
To determine whether P6 acustimulation is effective, it is important to compare the
intervention as a sole treatment vs. a sham or placebo treatment. During a placebo treatment, a
device is applied in a non-P6 location, or the illusion of P6 acupoint stimulation is provided
without giving an actual stimulus (Turgut et al., 2007). This provides an opportunity to gauge the
effectiveness of P6 acustimulation, and if found effective, compare it further with other
interventions. A variety of Randomized Control Trials (RCTs) have discovered that P6
acupressure is both effective and superior in reducing PONV in a variety of surgical patients
compared to a placebo group alone (Chen, Chang, & Hsu, 2005; Direkvand-Moghadam &
Khosravi, 2013; Ertas et al., 2015; Frey, Scharmann, Lohlein, Peters, 2009; Gan, Jiao, Zenn, &
Georgiade, 2004; Hickman, Bell, & Preston, 2005; Lee & Fan, 2011; Wang et al., 2011). Studies
vary in the percentage of PONV reduction that P6 acupressure provides, but all reduce it to a
clinically significant degree.
Direkvand-Moghadam and Khosravi (2013) performed a randomized control trial of 102
patients undergoing elective cesarean section. They found that acupressure decreased the
incidence of nausea to 20.58% compared to the control group of 50%. Vomiting was reduced
from 32.34% in the control group to 17.64% acupressure group. Furthermore, the need for a
rescue antiemetic was only 5.88% in the acupressure group compared to 20.58% in the control
group. In another randomized control trial, Wang et al. (2010) evaluated the effectiveness of P6
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acustimulation in 80 patients undergoing supratentorial craniotomy. The study concluded that the
prevalence of nausea and vomiting was significantly lower in the P6 acupoint group compared to
the control group, more specifically, “only 18% of P6 patients had nausea and vomiting in the
first 24 hours compared to 37% in the control group” (p. 130).
In a RCT consisting of 77 patients undergoing major breast surgery, Gan et al. (2004)
also found similar results. They discovered that satisfaction rate (no nausea, emesis, or use of
rescue antiemetic) was significantly higher in the acupressure group, compared to the placebo at
2 hours, and even up to 24 hours postoperatively, suggesting that the efficacy is prolonged past
the immediate post operative period. Interestingly, they also found that the group receiving
acustimulation “experienced lower pain scores in the PACU and fewer patients in this group had
severe pain” when compared to the control group (p. 1072). Although slightly varying degrees of
efficacy were noted among studies, all studies concluded that prophylactic stimulation of the P6
acupoint significantly reduces the prevalence of PONV in a variety of patient populations, and is
advantageous due the portability and easy of application.
P6 Acustimulation vs. Pharmacological Treatment
Controversy still continues surrounding the optimal strategy to manage and reduce
PONV, especially in regards to pharmacological management. Antiemetic drugs may carry
serious side effects such as hypotension, extrapyramidal effects, and QT prolongation (Ertaz et
al., 2015). Many factors surrounding pharmacological management are still unknown, and
universal treatment is neither cost effective nor necessary. Wakefield et al. (2002), described
droperidol as being the most cost effective antiemetic, while ondansetron remains superior as a
rescue antiemetic. The question remains that can an intervention such as P6 acupressure produce
comparable or even superior results of its pharmacologic counterpart?
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One of the most popular and widely administered antiemetics includes ondansetron.
Ondansetron is a competitive serotonin type 3-receptor antagonist (5-HT3), which blocks vagal
afferent stimuli through 5-HT3 receptors, thus preventing the vomiting reflex. In a randomized,
prospective, double-blind and placebo-controlled study conducted by Agarwal et al. (2002), 150
patients undergoing elective laparoscopic cholecystectomy were evaluated. The control group
was compared to a 4 mg prophylactic dose of ondansetron or P6 acustimulation, and the results
found that PONV in the first 6 hours following surgery was 44% in the control group, 10% in the
acupressure group, and 8% in the ondansetron group. The same study concluded that P6
acustimulation provides a significant reduction in the incidence of PONV and is as effective as a
4 mg prophylactic dose of ondansetron. Gan et al. (2004) completed a similar study that also
found P6 acustimulation to be equally effective as 4 mg of ondansetron. Although the incidence
of immediate PONV was slightly less in the ondansetron group, the 24-hour incidence of
vomiting was much lower in the P6 acustimulation group (19%), compared to the ondansetron
group (32%).
Although it is outside the focus of the research question, Coloma et al. (2002) performed
a RCT of 268 outpatients receiving ondansetron, P6 acustimulation, or a placebo, and they
discovered an interesting result. In addition to concluding that P6 acustimulation is comparable
in efficacy ondansetron, it was discovered that a higher percentage of patients in the
acustimulation vs. ondansetron group (70% vs. 33%) also reported a regular sleep pattern 24
hours following surgery (p. 1390). Results such as this may pave the way in discovering added
benefits in addition to PONV control while simultaneously reducing the need for
pharmacological antiemetics. Most importantly, numerous other randomized control trials have
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also established that P6 acustimulation is comparable in efficacy to ondansetron (Sharma &
Goswami, 2007; Misra, Pullani, & Mohamed, 2005; Sharma & Goswami, 2007).
When compared to other common antiemetic drugs such as metoclopramide, the results
are somewhat similar, while with others, such as dexamethasone are variable. Metoclopramide is
an antagonist of the dopamine D2 receptor subtype, providing an antiemetic action while
promoting gut motility. A randomized control trial of 120 children undergoing hernia repair,
circumcision, or orchidopexy compared the effectiveness of metoclopramide, P6 acustimulation,
and a placebo. The trial concluded that the control group had a higher incidence of PONV, and
that acupressure to the P6 site is equally as effective as metoclopramide in preventing PONV in
children (Butkovic, Toljan, Martolic, Kralik, & Radesic, 2005). Hickman et al. (2005) also noted
“stimulation of the P6 acupoint was as effective as 2 standard antiemetics; cyclizine, 50 mg and
metoclopramide, 10 mg” (p. 382). D2 receptor antagonists, such as metoclopramide are known
for their undesirable side effect of extrapyramidal effects, which may contraindicate their use in
a certain subset of patients. Although P6 stimulation may not abbreviate the same degree of
bowel transit time, it has demonstrated to be a viable alternative while providing the same effect
on PONV as metoclopramide (Direkvand-Moghadam, & Khosravi 2013).
The efficacy of dexamethasone, a well-known corticosteroid and anti-inflammatory, is
commonly used as an adjunct to the pharmacological management of PONV and not as a sole
antiemetic. Evidence lacks in direct comparison of P6 acupressure to dexamethasone. Therefor,
a recommendation cannot be made until further research is conducted, and dexamethasone could
be continued as an adjunct therapy to preventing PONV. Although there is literature to support
P6 acupressure being as effective as metoclopramide and other antiemetics such as ondansetron,
a strong argument to universally replace their therapy cannot be indisputably made at this time.
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P6 Acupressure Combined with Pharmacological Treatment
Evidence has been emerging in the effectiveness of P6 acustimulation compared to
traditional antiemetics but the question remains, is it the most efficacious way to use the therapy?
Combining P6 acustimulation with pharmacologic antiemetics, especially ondansetron, may
provide added PONV management that neither intervention could provide alone. For example,
the Coloma et al. (2002) study found that there were no significant differences between the
efficacies of ondansetron vs. acustimulation when either was used alone. However, when these
treatments were compared to combination therapy, “significantly more patients receiving the
combination therapy had no complaints of nausea or episodes of vomiting-retching” (p. 1390).
Lee & Fan (2011) also described in their Cochrane Review that participants who receive of
combination therapy of P6 acustimulation and ondansetron have a higher quality of recovery
than those receiving either intervention alone. Because there are no major added side effects, P6
acupoint stimulation may be best suited as an alternative to antiemetic drugs in low risk patients,
or in addition to antiemetic drugs for preventing postoperative nausea and vomiting in high-risk
patients.
Cost Analysis
Pharmacological antiemetic costs vary from hospital to hospital, and are largely
dependent on associated pharmaceutical companies (Nunley et al., 2008). Therefor, a risk benefit
and cost benefit analysis should be conducted by a facility to decipher a protocol to both
minimize PONV and associated hospital costs. The associated cost of using pharmacological
antiemetics includes acquisition cost, time, impact on discharge, and additional materials if
standard antiemetics fail. Nunley et al. (2008) found that each episode of vomiting adds an
additional “20-minute delay in post-anesthesia discharge, resulting in a cost of several hundred
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million dollars per year” (p. 254). It is clear that PONV is a valid and serious concern for the
financial well being of a facility.
Although the purpose of this review is not intended to provide a detailed cost analysis
among interventions, it is interesting to note that in the Gan et al. (2004) study,
The acupoint stimulation unit utilized costs $200 (including 2 battery changes) and is
reusable with disposable electrodes, which cost $1.84 for 4 electrodes (for each patient).
The cost for ondansetron 4 mg is $16.44 (including a 2-mL syringe and needle).
Assuming an acupoint stimulation unit is reusable in 200 patients, the direct cost
comparison is substantial (about $3000 for ondansetron versus $600 for acupoint
stimulation) (p. 1072).
The same study found that their patients would be willing to pay an average of “$56 - $100 for
an antiemetic that would eliminated PONV” (p. 1072). Other studies have used TENS units that
are reusable, and average a cost of $64, while some studies used less cost effective modes, such
as disposable devices for each patient. It is important to note that acustimulation via a nerve
stimulator can be performed routinely with virtually no added cost to the patient or hospital,
which would then only require a cost analysis of the hospitals current pharmacologic modalities.
The literature remains sparse in regards to cost analysis of P6 acustimulation, making further
research needed to provide an up-to- date and accurate cost analysis.
Timing of Application
The optimal timing of P6 acustimulation lacks clear consensus at this point. It has been
established that the mode of stimulation to the P6 site is insignificant, as long as the quality and
accuracy of stimulation is present. What is still not understood is if the timing of the stimulus is
of clinical importance. Studies vary in whether the stimulus is applied in a preoperative,
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intraoperative, or postoperative setting, with the majority of the studies focusing on the
application during the intraoperative period. A limited amount of research has been performed on
the optimal timing of P6 stimulation. In the study by Hickman et al., 2005 the complete response
rate was 68% when P6 stimulation was applied 30 minutes prior to surgery and 72 hours post
surgery, compared to only 43% when it was applied only 30 minutes prior to surgery. This
method may not be feasible in many circumstances, as the patient would have to be discharged
with the acustimulation device and ensure proper positioning for the following 72 hours. Frey et
al., 2009 performed a randomized control trial of 200 hundred women undergoing vaginal
hysterectomy. Participants were administered P6 acustimulation either pre-induction, postinduction, or given a placebo treatment. They found that there is no significant difference in
PONV reducing effects when P6 stimulation is applied pre-induction as apposed to postinduction and moreover, suggested that either method is equally as effective. Other trials have
found similar results (Cheong et al., 2013; Lee & Fan, 2011), and concluded that if an optimal
time to apply P6 acupressure exists, it remains unknown.
Side Effects
One of the most promising aspects associated with P6 acustimulation includes the
efficacy of the treatment while carrying a positive safety profile. Ertas et al. (2015) described the
use of various pharmaceutical agents occasionally carrying serious side effects as extrapyramidal
effects, hypotension, cardiac dysrhythmias, and prolongation of the QT interval. Side effects
such as these may limit or prevent the ability to use pharmacologic means of preventing PONV
in certain patients. The side effects of non-invasive P6 acustimulation are rare, occurring in only
3.3% of patients and included only minor erythema and swelling (Nunley et al., 2008). P6
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acustimulation can be used as an additional PONV adjunct therapy with no major added side
effects (Arnberger et al., 2007; Frey et al., 2009; Lee & Fan, 2011)
Literature Search
A comprehensive search was conducted to answer the following question: Does the
addition of Pericardium-6 acupoint stimulation decrease the incidence of post-operative nausea
and vomiting (PONV) when used alone, or in combination with other traditional pharmacologic
antiemetics? PubMed, CINAHL, and the Cochrane Library were the primary search engines used
to gather pertinent data. These were accessed through The University of North Dakota Harley E.
French Library of Health Sciences.
CINAHL was the first database utilized. Initial CINAHL headings used included “P6
stimulation”, which yielded 22 results. The search was modified using “P6 stimulation” AND
“PONV”, yielding 3 results. The English language and peer-reviewed limits were then set,
resulting in the same 3 articles. After review of the 3 articles, all were found to be pertinent to
the clinical question.
PubMed was the following database utilized. Medical subject heading terms “P6
stimulation” were used to focus the search initially. This resulted in 248 articles. The search was
refined using “P6 acustimulation” AND “PONV”, which yielded 14 results. Limits were then
added which included English language, human species, and publication dates within the past 10
years. This resulted in a more refined and recently published group of articles. After a detailed
review, 8 articles were found to be applicable.
The Cochrane Library was the last database used. The initial search criteria included the
key words “P6 stimulation” and “P6 acustimulation” both of which yielded the same 3 results.
The limits were then set to “Reviews”, yielding 2 high quality articles. The remaining 2 articles
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were analyzed and one article was determined to be a high quality Cochrane Review pertinent to
the research question.
After the initial literature search was complete through common databases, a total of 12
articles were obtained relevant to the research topic. Additional research means included
examination of the relevant articles reference sections, which yielded access to an additional 7
articles. Research was also conducted though The Cochrane Library’s Find Related Articles
Function, in which 5 additional articles were accessed. At the completion of a comprehensive
and thorough literature search, a total of 24 articles were collected to help answer the research
question.
Discussion
When comparing the literature review with the case study, some similarities exist.
According to Trueman (2011), the patient had the following PONV risk factors: young age,
female gender, non-smoker, anxiety, history of PONV, laparoscopic surgery, and use of
intraoperative opioids. In total, the patient had 7 risk factors, which placed her relative risk of
suffering PONV at “very high” (> 80%). According to the literature review, recommended
prophylaxis for this patient should include a multi-combination of anti-emetics, total intravenous
anesthesia with propofol, and some form of P6 acustimulation. The anesthetic plan therefor
would include a multimodal approach to ideally alleviate any PONV from occurring with the
patient. The literature does not detail the ideal combination of antiemetics, nor the ideal dosage
and timing of those drugs. A combination of 3 different antiemetics was chosen to occupy
multiple receptors in the vomiting center. The patient received a transdermal scopolamine patch
in the preoperative holding area, ondansetron 4 mg prior to induction, and dexamethasone 5 mg
immediately following induction. Anesthetic inhalational agents were to be avoided due to their
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known incidence of increasing PONV (Frey et al., 2009; Trueman, 2011, Wang et al., 2010).
Anesthetic vaporizers were secured with tape prior to the case to avoid accidental initiation of
any inhalational agent.
Determining the optimal stimulation method, timing, and duration of the P6 acupoint
presented the biggest challenge. The literature review has established that the method (invasive
vs. noninvasive) in which P6 acupoint stimulation is elicited is not of much importance
compared to the accuracy of the stimulus (Dundee, 1990; Dundee et al. 1989; Lee & Fan, 2011;
Trueman, 2011). For this reason, a peripheral nerve stimulator was chosen as the method to
deliver P6 acustimulation due to multiple factors. Monitoring of neuromuscular blockade is
standard in modern anesthesia, and necessary in this case due to the administration of the nondepolarizing neuromuscular blocker, rocuronium. The wrist was an easy accessible point on the
patient, due to the arms being suspended bilaterally on arm boards and adducted slightly less
than 90 degrees. This allowed the opportunity to provide supramaximal electrical stimulation of
the P6 acupoint, while measuring neuromuscular blockade via the median nerve at the same
time. It is also a safe, and cost effective manner to provide P6 acustimulation. In a prospective,
double-blind, randomized control trial, Kim et al. (2011) established that
Electrical stimulation of a peripheral nerve at the P6 acupoint improved PONV while
simultaneously measuring neuromuscular blockade. Tetanic stimulation at 50 Hz for 5
seconds every 10 minutes decreased the incidence of PONV from 70% to 15.4% for the
first 6 hours after surgery. (p. 821)
The P6 acupoint was located on the patient’s dominant hand, and the proximal positive electrode
was placed between the tendons of the palmaris longus and the flexor carpi radialis 1 cm
proximal to the P6 acupoint. The distal negative electrode was placed 2 cm distal to the P6
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acupoint. Each electrode was connected to the nerve stimulator and tetanic stimulation at 50 Hz
for 5 seconds was delivered every 10 minutes for the duration of the procedure following
induction of anesthesia. This followed the same strategy Kim et al. (2011) described in their
randomized control trial of 264 women undergoing laparoscopic hysterectomy, which concluded
P6 acustimulation with a nerve stimulator is effective in decreasing PONV. In a similar
prospective, double-blinded RCT, Arnberger et al. (2007) investigated 220 women undergoing
elective laparoscopic surgery. They utilized the same mode of P6 acustimulation, with the same
electrode placement, but applied single-twitch stimulation with “1 Hz (over 0.2 ms, at a constant
current of 50 mA) throughout the maintenance of anesthesia” (p. 904). Both studies described a
significant decrease in PONV when using their described strategy for the first 6 hours post
operatively, but found it less effective in the late postoperative period of 6-24 hours. Much like
the two prior studies, the patient in the case study denied any episodes of PONV in the first 6
hours. The patient also described no episodes of PONV for the late postoperative period of 6-24
either, demonstrating a more favorable outcome.
In a study completed by Arnberger et al. (2007), subjects were given sodium thiopental,
fentanyl, and rocuronium on induction, with Sevoflurane for maintenance anesthesia. Kim et al.
(2011) provided anesthesia for subjects in which they received remifentanil, sodium thiopental,
and rocuronium on induction, and anesthesia was maintained with Sevoflurane. An oral-gastric
tube was also inserted during the case in which the stomach was emptied of contents. Both
studies used glycopyrrolate and neostigmine in equivalent doses to reverse neuromuscular
blockade until twitches returned to 100%. Rescue antiemetics were only administered post
operatively if the subject displayed symptoms of PONV. Induction medications, maintenance
anesthesia, and the use of antiemetics in the literature review differed from the strategy presented
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in the case study. It is unknown to what degree these factors contributed to the reduction of
PONV in my patient.
The results of the presented case study showed promise in that unilateral stimulation of
the P6 acupoint while measuring neuromuscular blockade can be effective in reducing PONV in
the early postoperative period, as well as late postoperative period. It also provides strong
evidence that a multimodal approach to reducing PONV with the use of P6 acustimulation can be
extremely effective.
Evidence Based Recommendations
Based on the current literature search, four practice recommendations can be put forth for
anesthesia professionals to consider:
1. P6 acustimulation may be used as an alternative or adjuvant therapy for prevention of
postoperative nausea and vomiting in low to moderate risk patients. Aggressive universal
pharmacological prophylaxis is not effective in a risk to benefit ratio (Stoelting & Hillier,
2004). Due to its low cost, favorable side-effect profile, and relative efficacy, P6
acustimulation could be recommended for universal prophylaxis, or possibly replacing
the use of a single prophylactic pharmacological dose of antiemetic.
2. In high-risk patients (with four or more risk present risk factors), P6 acustimulation
should be used in conjunction to pharmacological prophylaxis as a multi-modal approach.
This combination has shown to be significantly effective in high-risk patients to reduce
vomiting and retching (Frey et al., 2009).
3. P6 acustimulation should be used in conjunction to pharmacological methods as a multimodal approach in patients who may suffer from potential catastrophic consequences of
PONV. Wang et al. (2010) suggested that in patients who have the potential for
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catastrophic consequences, “if such a risk cannot be excluded, a multimodal antiemetic
approach should be considered, regardless of individual risk factors” (p. 130).
4. Additional randomized control trials with large sample sizes should be conducted to
determine the optimal timing and duration of P6 acustimulation. Establishing clear
guidelines on application and duration will provide anesthesia providers with an optimal
strategy to maximize the benefits of P6 acustimulation and further reduce PONV.
Conclusion
Post-operative nausea and vomiting is one of the most common side effects following
anesthesia, capable of causing the patient severe mental and physical distress, prolong PACU
stays, and increase healthcare costs. Pharmacological means of prophylaxis have been the
mainstay treatment in the past. Although proven effective, they are also costly, have potential life
threatening side effects, and do not eliminate PONV. Side effects and cost profiles of
pharmacological antiemetics reinforce the broadly held belief that there remains opportunity for
improvement.
The addition of P6 acustimulation has been suggested as an alternative to, or in
conjunction with current pharmacological treatment, while carrying a cost effective and safe
method for PONV prophylaxis. P6 acustimulation can also be suggested for use in combination
therapy for those patients at high risk. The findings of this paper support the implementation of
P6 acustimulation within the modern clinical practice; however further research is desired on the
optimal timing and duration of application.
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